Project BASE: Changing Behaviour towards Aerobic and Resistance Exercise
Engaging in physical activity is beneficial to the wellbeing of people with MS. The aim of the study is to assess the feasibility of a study designed to involve people with MS in an exercise program. You’ll take part in a four-month at home exercise program, guided by our team of BASE physiotherapists, occupational therapists […]
Australian Physiotherapy and Occupational Therapy insights on implementing beach-based therapeutic interventions for people with disability
This survey aims to: (i) Identify the benefits, barriers, and facilitators of beach access for people with disability. (ii) Explore how the beach could be used as a setting for therapeutic interventions.
Social connectedness and long-term health conditions
This is a qualitative research study that aims to gain a better understanding of the experiences of loneliness of people living with long-term health conditions (such as MS). We have already finalised recruitment for participants living with long-term health conditions and are now seeking health- and community-care professionals who provide care and support for people […]
Investigating social cognitive factors associated with chronic non-cancer pain and pain management
Do you have chronic pain? Researchers from The University of Queensland are looking for people aged 18 and over to participate in a short 20-minute online survey to understand the thoughts and feelings that might influence pain management. Participants will go into the draw to win 1 of 2 $100 gift cards. For more information […]
The Wellbeing Neuro Course: A Randomised Controlled Trial of an Online Treatment Program for Adults with Multiple Sclerosis
Mental health (e.g., anxiety, depression) and functional difficulties (e.g., cognitive problems) are highly comorbid in people with Multiple Sclerosis (MS). However, access to effective psychological treatments are limited. People with MS face many barriers (e.g., costs, limited trained clinicians, mobility issues) accessing effective psychological care. The Wellbeing Neuro Course offers an innovative solution to these […]
Reducing the frequency of Autoimmune adverse events in the treatment of Multiple sclerosis with alemtuzumab using B-celL dEpletion (RAMBLE): a phase II, randomised, placebo-controlled clinical trial
To reduce the occurrence of autoimmune adverse events from the treatment of multiple sclerosis (MS) with alemtuzumab through the subsequent targeted use of rituximab. The hypothesis to be tested is that rituximab therapy following alemtuzumab treatment for MS will reduce the frequency of autoimmune adverse events. If this strategy proves to be safe and is […]
An investigation of a novel mechanism of obstructive sleep apnoea (OSA) in people with Multiple Sclerosis (MS)
Multiple sclerosis (MS) and obstructive sleep apnoea co-occur frequently with shared symptoms such as fatigue, depression and cognitive impairment which when together may be more severe and difficult to manage. The mechanisms for the high prevalence of sleep apnoea in people with MS are unclear. Understanding the causes of sleep apnoea in people with MS […]
MINDS-MS: Improving the detection and treatment of depression in multiple sclerosis
This research will assess knowledge, current practices, barriers and required supports to improve the detection and treatment of depression in people with MS. It assesses this from the perspective of what people with MS have experienced and believe will assist to improve healthcare support. This information will be used to develop tools, resources and guidelines […]
Assessing Lower Limb Strength and Walking Ability in Individuals with Multiple Sclerosis
The research study aims to investigate strength in the lower limb and its association with walking ability. In addition, other factors related to Multiple Sclerosis (MS) that may affect walking, including spasticity, balance, leg sensation and contractures in the ankle, will be assessed. We hope to use the information we get from this research study […]
A Phase 3, Randomized, Double-Blind, Efficacy and Safety Study Comparing SAR442168 To Placebo In Participants With Primary Progressive Multiple Sclerosis (PERSEUS)
SAR442168 is being developed for the indication of treatment of patients with MS. This study is designed to collect evidence of efficacy and safety of the drug. The goal of this Phase 3 clinical trial is to demonstrate the efficacy and safety of SAR442168 compared to placebo in participants with primary progressive multiple sclerosis (PPMS). […]